chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist via company representative and refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX vial 19400 plaque forming units (PFU) (dose, route of administration, lot# and expiry date were not provided) for prophylaxis. On an unknown date the patient experienced trigeminal neuralgia-like symptoms of unclear etiology but chronologically close to the timing of ZOSTAVAX immunization. The outcome of trigeminal neuralgia-like symptoms was unknown. The relatedness between the event and ZOSTAVAX was not provided. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1902USA006444.
This spontaneous report as received from a pharmacist refers to a 60 year old male patient with high blood pressure, high cholesterol, diabetes and no drug reactions/allergies. On 22-OCT-2014, the patient was vaccinated with ZOSTAVAX (lot # K009199, expiration date 27-SEP-2015), (dose and frequency not provided) subcutaneous. Concomitant therapies included metformin, hydrochlorothiazide (HCTZ) (manufacturer unknown), VICTOZA, CRESTOR, LEVEMIT and lisinopril (manufacturer unknown). On 23-OCT-2014, the patient developed soreness and redness at the ZOSTAVAX injection site. On 24-OCT-2014 the patient developed shingles on the head. On 24-OCT-2014, the patient started acyclovir (manufacturer unspecified) therapy. No lab diagnostics studies were performed. The patient went to see a physician. The patient was recovering. Additional information has been requested.
Appeared to have breath holding spell after imms. Cried intensely sudden silence went red-> pale, Leaned head against mom went very still with eyes shut no seizure like movement. By time MD arrives (approximately 1 min) waking up & typical then asleep/napping by time of departure.
Patient came in for a covid vaccination but was entered in the computer for a Flu vaccine and received a Flu shot instead of a Covid shot. No Adverse reactions occurred to patient.
THE RIGHT DELTOID STARTED TO SWELL ABOUT 20 MINUTES AFTER THE INJECTION. IT CONTINUED TO SWELL AND SPREAD DOWN THE ARM TO 4 INCHES BELOW THE ELBOW AND INTO THE RIGHT SIDE OF HER CHEST. SHE REPORTS SHE EXPERIENCED NAUSEA, ACHES AND PAINS, EMOTIONAL INSTABILITY, AND LOSS OF SLEEP.
shingles; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported similar events for two patients. This is the 2nd of two reports. A 56-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration, administered on the arm on 04Mar2021 at a single dose for COVID-19 immunisation. The patient had no relevant medical history and patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 09Feb2021 at a single dose for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered: Hospital. On 14Mar2021, patient experienced shingles (reported as approximately 7-10 days after vaccination). Patient resumed use of valacyclovir (VALTREX) as a result of the event. The outcome of shingles was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021443578 Same reporter, drug, and event; different patient
Severe Diarrhea, vomiting, sweating  2 days after administration lasting for 5 hours.  2 weeks of constant nausea.
Sore arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No medical history was provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (unknown route) UNK dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Reporter did not allow further contact
Client received vaccine @ 9:45 am.  Came to see nurse @ 11:55 am c/o vomiting & wanting to go home.  Juice given.  Student stated that she felt the same way when she had other medicine in past.  At 12:08 pm, PHN called over.  Student pale, semi-conscious & having seizure-type activity.  PHN & school nurse could get her to respond by nodding & she lifted arm for BP.  Seizure-type activity from shoulders down.  On assessment denied itching but nodded head to SOB & throat closing.  Epinephrine given @ 12:12 pm.  Rescue squad called/mom called when incident began.  Transported to ER via squad @ 12:20 pm.  12/3, spoke to mom:  same reaction when teen took mom's Imatrex- seen in ER.  ER stated it was rxn to Imatrex.  12/4/09:  TC from mom - another incident at 6:30 pm last evening & 1 at hospital.  DX with pseudo seizures & placed on amitriptyline 10 mg.  F/U in a week.
Patient stated that he ended up in hospital for 6 weeks with Gullian-Barre syndrome. He was in the hospital for 2 weeks and then a rehab facility for 6 weeks. He said that he may be 90% back to his old self today (12/22/18).
48 yo healthy male no PMH - recent L leg fracture 10 months ago and has had  surgeries for this -- no known allergies or other medical issues  After 5 minutes --had swelling L ankle and then subsequently had paresthesias to L upper thigh and L arm and L chest No CP or SOB No fever or chills VItals normal 133/89 T 97.6 PO 97% P 68  Neuro exam: CN 2-XII intact Strength 5/5 + and symm bilat UE/LE Ambulatory No sensory difference No airway compromise   Observed for 1 hour and feels slightly better --no worsening symptoms - L arm /chest tingling is gone, mild symptoms L ankle
Pt succumbed to COVID-19 virus on 9/12/2021 after being diagnosed on 8/28/21.
Severe relapse of Nephrotic syndrome with massive proteinuria. Patient was off of steroids since 12/2019 and was  in complete remission. Proteinuria started about 4-5 weeks after 1 dose.
Pt experienced a localized injection size reaction, started with a quarter size red bump and progressed to a welt as large as a fist. The patch was red and hot to the touch and itchy. The pt was referred to primary care for further evaluation, and recommendation as to whether pt should receive the second dose in the series.
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine (diptheria crm197 protein) injection) was received from a healthcare professional regarding an infant who experienced pyrexia and irritability post vaccination. The patient received the first dose in Jan-2003. The patient also received the first dose of Haemophilus Influenzae B (manufacturer unknown) and a dose of Pediarix (Glaxosmithkline) (diptheria/tetanus/acellular pertussis/hepatits b vaccine/polio virus inactivated) on an unspecified date in Jan-2003. Medical History: Relevant medical history was not provided.  Product Details: Indication for Prevnar was immunization. Product was administered an unspecified date in Jan-2003. Dose regimen was one dose. Concomitant Therapy: Concomitant medications were not reported.  Event Details: Six to eight hours post-immunization, the infant experienced pyrexia ranging from 102 to 103 degrees F. (pyrexia) and irritability post vaccination (irritability) in Jan-2003. The infant experienced an injection site reaction at the Pediarix administration site. This report was received from GSK (A0423044A). No additional informatin was available at the time of this report.
Information has been received from a physician and nurse concerning a 22 year old female who on unspecified dates was vaccinated with all three 0.5 ml doses of GARDASIL (therapy route and lot # not provided). On an unspecified date, the patient tested positive for human papillomavirus (HPV). It was unknown whether patient sought medical attention. At the time of reporting, the patient's status was not provided. Follow-up information has been received on 07-JUN-2011 from a physician and medical records concerning a 22 year old female. No pre-existing allergies, birth defects, medical conditions and/or adverse events following prior vaccination were reported. On 20-SEP-2007, the patient received first dose of GARDASIL (lot # 658560/1062U) intramuscular injection. On 27-NOV-2007, the patient received her second dose of GARDASIL (lot # 659055/1522U) left arm. On 24-MAR-2008, the patient received her third dose of GARDASIL (lot # 659964/1978U) left arm. The physician noted on 08-MAR-2011 at 11:40, results from a cytology report of the cervix/endocervix showed atypical squamous cells of undetermined significance and human papillomavirus ad HPV (high risk for HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68). The physician considered the events to be other important medical events. The physician reported the patient had recovered. All available medical records will be provided upon request. Additional information has been requested.
Fever of up to 103.7, lasting through today (3.5+ days) Body aches Arm tenderness at injection site
The following morning I woke up with a migraine that by mid-day was a regular headache; Late morning I began experiencing flu-like symptoms; Muscle and joint aches; Muscle and joint aches; Slight cough; Fever; Chills; Loss of appetite; Approximately 6 hours after vaccine I became nauseous; Migraine, ocular migraine began approximately 4 hours after vaccine. Ocular migraine went away after an hour.  Migraine remained; Migraine, ocular migraine began approximately 4 hours after vaccine. Ocular migraine went away after an hour.  Migraine remained; This is a spontaneous report from a non-contactable consumer (patient). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Mar2021 11:00 (at the age of 52-year-old) (Lot number and expiration date was not reported) as dose number unknown, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included none. The patient did not have any known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. On 02Mar2021 16:00, the patient experienced migraine, ocular migraine began approximately 4 hours after vaccine. Ocular migraine went away after an hour. Migraine remained, and approximately 6 hours after vaccine, the patient became nauseous. The following morning (03Mar2021), patient woke up with a migraine that by mid-day was a regular headache and late morning the patient began experiencing flu-like symptoms and had muscle and joint aches, slight cough, fever, chills, and loss of appetite. The patient did not receive any treatment for the events. The outcome of ocular migraine was recovered and all other events were recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Immediately that evening, I started to get headachy and nauseous. My arm in the injection site was very sore. The next morning, the other arm was sore. It was difficult for me to raise my arms above my head without feeling extremely weak. I couldn't lift anything above my head for the fear I would drop them. Knee replacement surgery on both knees about 4 years ago - I felt pain in my knees; all my joints; all of my teeth; my vision was blurry. My head hurt so badly. Tylenol dulled the headache and joint pain but it didn't help it to go away. My chest also hurt quite a bit. I felt extremely lethargic.  I didn't feel like getting out of bed. I could only get the  meals  made (I'm a caregiver for my mom and mother-in-law) and then get back into bed. I usually walk five miles a day. I'm still not there yet ( to walk that much) but I'm getting better. The nausea lasted until the 17th. The headache just left finally on April 23. The body aches, teeth ache and joints subsided around the 17th also. The blurry vision - I still have a a little bit of that but it's starting to improve. The weakness in the arm - that is starting to improve - I do still feel kind of weak when I raise my arms above my head. The fatigue I still have but I'm feeling a bit of improvement.  I have to keep checking my bed to see if I accidentally put the massage setting on (and I hadn't) because my body was shaking  in entire  body- That started on the second day after the vaccine and stopped about the 19th. I called to the advice nurse to register my health complaint and she had me come in for a full workup. And she asked me to go to ER. They kept me in the ER overnight.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 65-year-old female patient who received Shingrix for prophylaxis. The patient's past medical history included fibromyalgia, sjogren's disease, hypothyroidism and white blood cell count low. Previously administered products included Shingrix with an associated reaction of pyrexia (all other events experienced after dose 1 received on 3rd August 2018, refer case US2018188648) and Zostavax. On 10th October 2018, the patient received the 2nd dose of Shingrix (intramuscular) 50 ug. On 10th October 2018, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, feeling cold, fever, pain in arm, fatigue, night sweat, sweating, feeling unwell and injected limb mobility decreased. In October 2018, the patient experienced neck pain and headache. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms, neck pain, headache, feeling cold, fatigue, night sweat, sweating and feeling unwell were not recovered/not resolved and the outcome of the fever, pain in arm and injected limb mobility decreased were recovering/resolving. The reporter considered the influenza-like symptoms, neck pain, headache, feeling cold, fever, pain in arm, fatigue, night sweat, sweating, feeling unwell and injected limb mobility decreased to be related to Shingrix. Additional details were provided as follows: The patient had fibromyalgia, Sjogren's disease, and hypothyroidism, low white blood cell count and weakened immune system (all conditions prior to receiving Shingrix vaccine). Later that day of vaccination the patient suddenly started feeling sick with flu like symptoms. She had a fever of 101 F that night, and the next day, 11th October 2018, her fever was 103 F. She started having night sweats that would soak the bed, but would also feel like she was freezing. The sweating was now happening during the day as well. Her arm was very sore after the injection and she had a hard time moving it. The soreness was getting better at the reporting time, but she had pain in her neck that shoots up to her head that she had never had before. 1 to 2 days after receiving Shingrix, the patient experienced headaches. The patient felt a sharp pain in her head and when she turns her head she hears a crackling sound. The fever comes and goes, but at the reporting time, it was about 100 F when it occurred. She saw her doctor on 15th October 2018 about her symptoms and the doctor thought they are related to Shingrix. Her Complete Blood Count (CBC) came back normal. The patient was still feeling sick and fatigued. The patient stated that she was scheduled to have an MRI the upcoming Friday from the date of reporting. The contact details of physician were provided.
I experienced an attack of Vertigo 13 days after my first shot, and again 12 days after my second shot. Severe symptoms for 24 hours, then milder for the next 5-6 days.
first dose a year ago; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose a year ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient inquired if he should restart series or when should he receive the second dose to which the call center representative provided medical advice disclaimer. No additional details were provided by reporter. The reporter did not consent to follow up.
Pt. reports waking around 6am on Saturday, March 6th with a temperature, headache, body aches and nausea.  She reports that this lasted all day on Sunday, March 7th as well. Woke Monday, March 8th and Tuesday March 9th fatigued and rested or slept most of the day. Pt. was advised that she could use Tylenol for fever and generalized achiness.  Pt. woke today, Wednesday, March 10th with no symptoms and felt "like her normal self".
Conjunctivitis of bilateral eyes. Onset 1 day following vaccination. No treatment.
on 7/10 pt was seen for a nurse visit. Pt requested a Covid vaccine. Pt received moderna bivalent 6 months to 5 years dark pink cap .Pt was to receive moderna bivalent 6 months and up dark blue cap. Spoked with Dr. no concerns regarding the dose the pt recieved. Contacted pt mother with, pt mother said pt is doing well and rescheduled to come in on monday 7/17/23 to be re vaccinated with appropriate vaccine. .
ACUTE DVT, UNSPECIFIED VEIN HYPOTENSION 1/28/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
After receiving 2nd vaccine on 2/14/2021, she experienced chills and body aches for 72 hrs. No medication intervention needed.
Information has been received from a consumer, for GARDASIL, a Pregnancy Registry product, concerning her daughter an 18 year old female with an unspecified sexually transmitted disease who received unspecified pills for the infection who on 22-JAN-2009 (2 weeks ago on a Thursday) was vaccinated with the first dose of GARDASIL. The physician said the patient was not pregnant, but the mother believed she was, because "her stomach is really swollen and she used to be thin". At the time of the report the outcome of the patient was unknown. The patient was seen by the physician in office. No further information is available.
complained of numbness on one side of his face, used to be severe but is now milder, but still there; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE , Batch/Lot No: Unknown., Site of administration: Unknown), for COVID-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious), outcome "recovered with sequelae", described as "complained of numbness on one side of his face, used to be severe but is now milder, but still there". The event "complained of numbness on one side of his face, used to be severe but is now milder, but still there" required physician office visit. It was unknown if therapeutic measures were taken as a result of hypoaesthesia.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Began with hives, paleness, hoarseness, hot flash, then over coarse of 4 days worsening symptoms of weakness, fever, aches, cough and dizziness.
itchy puffy red blotchy rash about 4 inches across on left shoulder at site of injection which appeared 8 days after the vaccine
Blood running down in places; Fell up the steps/down the steps; Scratched in places; Bruised in places; Hurt from head to toe; This spontaneous case was reported by a patient and describes the occurrence of WOUND (Blood running down in places), FALL (Fell up the steps/down the steps), SCRATCH (Scratched in places), CONTUSION (Bruised in places) and PAIN (Hurt from head to toe) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknwn) for COVID-19 vaccination.     The patient's past medical history included Difficulty in walking (trouble in her legs in the past). Concurrent medical conditions included Stomach discomfort. Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]) for an unknown indication.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced WOUND (Blood running down in places), FALL (Fell up the steps/down the steps), SCRATCH (Scratched in places), CONTUSION (Bruised in places) and PAIN (Hurt from head to toe). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, WOUND (Blood running down in places), FALL (Fell up the steps/down the steps), SCRATCH (Scratched in places), CONTUSION (Bruised in places) and PAIN (Hurt from head to toe) outcome was unknown.            Additional concomitant medications included a stomach tablet for stomach discomfort and Pemprol.  Patient stated she did not believe the fall was from  the Moderna vaccine because she moved the steps.
patients symptom onset began on 1/4/2021 , 5 days after vaccine was administered symptoms include fatigue and mild cough.
After 3rd injection (MMR) patient cried. Mom picked him up and his eyes rolled back and felt limp. No cyanosis or apnea. Last approximately 5 sec to 30 sec and self resolved. Subdued after, but returned to baseline.
Bexsero given @ 10:30 am on 7/28/19. At 12 noon pt experienced fever, headache, muscle + joint pain. 2 pm. Temp 100.7 severe headache, joint pain. Swelling + pain @ injection site. Couldn't move (L) arm
This spontaneous report as received from a physician refers to a 9 month old patient. Pertinent medical histories and concurrent conditions were not reported.  On 24-FEB-2017, the patient was vaccinated with VAQTA (dosage regimen were not reported) for prophylaxis ( product use issue). No adverse effects were reported (no adverse event). All of the data listed were reconfirmed with the reporter. No further information provided. Additional information has been requested.
Fever of 101.5 Chills/body aches Muscle stiffness General malaise Nausea Headache